Bio-Techne Corp. buy Citigroup Inc.
Start price
21.08.25
/
50%
€46.80
Target price
21.08.26
€60.09
Performance (%)
35.09%
Price
24.07.26
€62.98
Summary
This prediction is currently active. With a performance of 35.09% the BUY prediction by Citigroup_Inc_ is a big success. Dividends of €0.24 are taken into consideration when calculating the performance. This prediction currently runs until 21.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -0.095% | -0.095% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $70.00 price target on the stock, up previously from $55.00.
Ratings data for TECH provided by MarketBeat